Machina Capital’s Guardant Health GH Stock Holding History

Machina Capital’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$2.34K	–	366
2023 Q1	$2.34K	Buy	+100	New	+$2.86K	﹤0.01%	459

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Machina Capital's GH Position: Q2 2023 in Review

Machina Capital sold out of Guardant Health (GH) in Q2 2023, closing a stake of 100 shares — an estimated $2.34K sold.

Machina Capital first reported a position in GH in Q1 2023 and held it in 1 quarter. The position peaked at $2.34K in Q1 2023. 299 funds tracked by Wall St. Rank hold GH as of Q2 2023.

Machina Capital reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
Machina Capital sold 100 Guardant Health shares in Q2 2023, an estimated $2.34K.
Machina Capital first reported a position in Guardant Health in Q1 2023 and held it in 1 quarter.
Machina Capital's Guardant Health position peaked at $2.34K in Q1 2023.
299 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Machina Capital's 13F filing for Q2 2023, filed 8 Aug 2023.